FDA report highlights need to improve diversity in clinical trials
There has been a real push among the industry to improve diversity in trials. The FDA report shows diversity statistics from US trials.
There has been a real push among the industry to improve diversity in trials. The FDA report shows diversity statistics from US trials.
Sipavibart demonstrated to offer a statistically significant decline in the symptomatic Covid-19 occurrence.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of new treatment...
NeuroSense taps PhaseV’s ML tech for Phase III ALS trial analysis
MMI pioneers Symani Surgical System in first US cases
“Defensibility” key for AI-centric small biotechs seeking investment
Klineo wins €2m to advance AI patient recruitment platform